rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2006-8-21
|
pubmed:abstractText |
The differentiation of adrenocortical carcinomas from adenomas may be difficult based on morphology alone. Differential expression of insulin-like growth factor (IGF) II and cyclin-dependent kinase (CDK) 4 has recently been described in these tumours. The aim of this study was to investigate the diagnostic usefulness of these markers immunohistochemically.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0309-0167
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
298-307
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16918977-Adrenal Cortex Neoplasms,
pubmed-meshheading:16918977-Adrenocortical Adenoma,
pubmed-meshheading:16918977-Adrenocortical Carcinoma,
pubmed-meshheading:16918977-Adult,
pubmed-meshheading:16918977-Aged,
pubmed-meshheading:16918977-Cyclin-Dependent Kinase 4,
pubmed-meshheading:16918977-Diagnosis, Differential,
pubmed-meshheading:16918977-Golgi Apparatus,
pubmed-meshheading:16918977-Humans,
pubmed-meshheading:16918977-Immunohistochemistry,
pubmed-meshheading:16918977-Insulin-Like Growth Factor Binding Protein 2,
pubmed-meshheading:16918977-Ki-67 Antigen,
pubmed-meshheading:16918977-Middle Aged,
pubmed-meshheading:16918977-Sensitivity and Specificity,
pubmed-meshheading:16918977-Tumor Markers, Biological,
pubmed-meshheading:16918977-Tumor Suppressor Protein p53
|
pubmed:year |
2006
|
pubmed:articleTitle |
IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.
|
pubmed:affiliation |
Institute for Surgical Pathology, Department of Pathology, University Hospital Zurich, Switzerland. anja.schmitt@usz.ch
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|